The pathogenesis of DM is still unclear, although it is likely associated with inappropriate complement activation and interferon (IFN) response (4, 5), which results in the production of myositis-specific autoantibodies that may be related to unique clinical features. This evidence concerns the gene IFNA1 and myositis disease.